Excessive spot weld time may cause the electrode tips to mushroom, resulting in no focus of current and a weak weld.

Binimetinib is given in combination with encorafenib as each drug targets a different kinase in the RAS/RAF/MEK/ERK pathway to stop malignant cell proliferation and to tell the cells to die (undergo apoptosis). … Terminal half-life of binimetinib is 3.5 hours. … No clinically significant changes in binimetinib exposure were seen in patients with severe renal impairment.

Yes those are two classics as well, often mumble those at weirdly appropriate moments (aka when no one but myself and another Pythonist will hear them!)

Have you done your wassail? 'Tis a handsome, drowsy ditty, I'll assure you.